RGEN · Repligen Corp · Earnings Call Transcripts & Audio
$186.00
-6.23 (-3.24%)
At close · Oct 1
Return incl. dividend (before tax)
Market Cap
$10.70B
Shares
56.44M
Volume · Oct 1
338.05K
Avg daily vol (3M)
1.09M
Repligen Corp Earnings Call Transcripts
Quarterly earnings calls for Repligen Corp (RGEN), with available speaker-labelled transcripts, captured audio replays, call highlights, 8-K earnings releases and periodic filings. Investor days and conferences appear here too.
Revenue & result across quarters
Revenue Net income YoY up YoY down artefacts
▲12.6%
$200.74M
$40.41M
'22 Q3
22-11-01
▲0.1%
$186.76M
$48.73M
'22 Q4
23-02-22
▼19.9%
$165.38M
$15.34M
'23 Q1
23-05-02
▼23.3%
$159.17M
$19.79M
'23 Q2
23-08-02
▼29.7%
$141.19M
$16.92M
'23 Q3
23-10-31
▼10.8%
$166.62M
−$16.45M
'23 Q4
24-02-21
▼7.4%
$153.18M
$3.30M
'24 Q1
24-05-01
▼0.2%
$158.84M
$5.71M
'24 Q2
24-07-30
▲9.7%
$154.87M
−$654,000
'24 Q3
24-11-12
▲0.6%
$167.55M
−$33.87M
'24 Q4
25-02-20
▲10.4%
$169.17M
$5.83M
'25 Q1
25-04-29
▲14.8%
$182.37M
$14.87M
'25 Q2
25-07-29
▲21.9%
$188.81M
$14.91M
'25 Q3
25-10-28
▲18.1%
$197.91M
$13.29M
'25 Q4
26-02-24
▲14.8%
$194.25M
$8.33M
'26 Q1
26-05-05
LATEST
▲11.9%
$204.13M
$5.01M
'26 Q2
26-07-28
Conference
Investor event
2026-09-09
Repligen Corp (RGEN) September 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q2
2026-07-28
Repligen Corp (RGEN) Q2 2026 Earnings Call Transcript
Confident tone
Protein franchise growth
BioLife acquisition (cell therapy)
Analytics franchise momentum
Revenue
$204.13M
▲ 11.9% YoY Diluted EPS
$0.09
▼ 65.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Conference
Investor event
2026-07-22
Repligen Corp (RGEN) July 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Conference
Investor event
2026-06-03
Repligen Corp (RGEN) June 2026 Conference Transcript
No reported result — non-financial event
Audio
Transcript
Slides
Earnings call
FY26 · Q1
2026-05-05
Repligen Corp (RGEN) Q1 2026 Earnings Call Transcript
Confident tone
Analytics Franchise Growth
Margin Expansion / Transformation Office
Polymem Divestiture
Revenue
$194.25M
▲ 14.8% YoY Diluted EPS
$0.15
▲ 50% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q4
2026-02-24
Repligen Corp (RGEN) Q4 2025 Earnings Call Transcript
Confident tone
Capital equipment and CapEx demand
2026 guidance and outlook
Services growth opportunity
Revenue
$197.91M*
▲ 18.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY25 · Q3
2025-10-28
Repligen Corp (RGEN) Q3 2025 Earnings Call Transcript
Confident tone
Franchise Performance
End Market and Geographic Strength
New Modalities
Revenue
$188.81M
▲ 21.9% YoY Diluted EPS
$0.26
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q2
2025-07-29
Repligen Corp (RGEN) Q2 2025 Earnings Call Transcript
Confident tone
New Modalities / Gene Therapy Headwind
Organic Revenue Growth and Order Momentum
China and APAC Regional Outlook
Revenue
$182.37M
▲ 14.8% YoY Diluted EPS
$0.26
▲ 160% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY25 · Q1
2025-04-29
Repligen Corp (RGEN) Q1 2025 Earnings Call Transcript
Confident tone
Orders momentum
Strategic initiatives and M&A
Customer diversification and geographic exposure
Revenue
$169.17M
▲ 10.4% YoY Diluted EPS
$0.10
▲ 66.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q4
2025-02-20
Repligen Corp (RGEN) Q4 2024 Earnings Call Transcript
Confident tone
Revenue and orders momentum
CDMO and equipment recovery
Hardware platform wins
Revenue
$167.55M*
▲ 0.6% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY24 · Q3
2024-11-12
Repligen Corp (RGEN) Q3 2024 Earnings Call Transcript
Confident tone
Orders and backlog momentum
Regional performance and China headwind
Filtration franchise
Revenue
$154.87M
▲ 9.7% YoY Diluted EPS
$-0.01
▼ 103.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q2
2024-07-30
Repligen Corp (RGEN) Q2 2024 Earnings Call Transcript
Positive tone
2024 guidance and FX
CDMO order recovery
China demand weakness
Revenue
$158.84M
▼ 0.2% YoY Diluted EPS
$0.10
▼ 71.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY24 · Q1
2024-05-01
Repligen Corp (RGEN) Q1 2024 Earnings Call Transcript
Positive tone
Order trends and book-to-bill
Filtration franchise strength
Proteins / affinity ligand headwind
Revenue
$153.18M
▼ 7.4% YoY Diluted EPS
$0.06
▼ 77.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q4
2024-02-21
Repligen Corp (RGEN) Q4 2023 Earnings Call Transcript
Positive tone
M&A / Metenova Integration
Market Recovery Indicators
China Deterioration
Revenue
$166.62M*
▼ 10.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY23 · Q3
2023-10-31
Repligen Corp (RGEN) Q3 2023 Earnings Call Transcript
Revenue
$141.19M
▼ 29.7% YoY Diluted EPS
$0.30
▼ 57.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Repligen Corp (RGEN) Q2 2023 Earnings Call Transcript
Revenue
$159.17M
▼ 23.3% YoY Diluted EPS
$0.35
▼ 60.2% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY23 · Q1
2023-05-02
Repligen Corp (RGEN) Q1 2023 Earnings Call Transcript
Revenue
$165.38M
▼ 19.9% YoY Diluted EPS
$0.27
▼ 66.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q4
2023-02-22
Repligen Corp (RGEN) Q4 2022 Earnings Call Transcript
Revenue
$186.76M*
▲ 0.1% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY22 · Q3
2022-11-01
Repligen Corp (RGEN) Q3 2022 Earnings Call Transcript
Revenue
$200.74M
▲ 12.6% YoY Diluted EPS
$0.71
▲ 22.4% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q2
2022-08-02
Repligen Corp (RGEN) Q2 2022 Earnings Call Transcript
Revenue
$207.63M
▲ 27.4% YoY Diluted EPS
$0.88
▲ 37.5% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY22 · Q1
2022-04-27
Repligen Corp (RGEN) Q1 2022 Earnings Call Transcript
Revenue
$206.40M
▲ 44.5% YoY Diluted EPS
$0.81
▲ 55.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q4
2022-02-17
Repligen Corp (RGEN) Q4 2021 Earnings Call Transcript
Revenue
$186.52M*
▲ 71.7% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY21 · Q3
2021-10-28
Repligen Corp (RGEN) Q3 2021 Earnings Call Transcript
Revenue
$178.22M
▲ 89.5% YoY Diluted EPS
$0.58
▲ 114.8% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q2
2021-07-27
Repligen Corp (RGEN) Q2 2021 Earnings Call Transcript
Revenue
$162.96M
▲ 86.3% YoY Diluted EPS
$0.64
▲ 113.3% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY21 · Q1
2021-05-04
Repligen Corp (RGEN) Q1 2021 Earnings Call Transcript
Revenue
$142.84M
▲ 87.7% YoY Diluted EPS
$0.52
▲ 188.9% YoY
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q4
2021-02-24
Repligen Corp (RGEN) Q4 2020 Earnings Call Transcript
Revenue
$108.65M
▲ 56.4% YoY Diluted EPS
$0.36
▲ 414.3% YoY Gross margin
55.7%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Earnings call
FY20 · Q3
2020-11-05
Repligen Corp (RGEN) Q3 2020 Earnings Call Transcript
Revenue
$94.06M
▲ 35.4% YoY Diluted EPS
$0.27
▲ 800% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q2
2020-07-30
Repligen Corp (RGEN) Q2 2020 Earnings Call Transcript
Revenue
$87.46M
▲ 23.7% YoY Diluted EPS
$0.30
▲ 76.5% YoY Gross margin
57.9%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY20 · Q1
2020-05-06
Repligen Corp (RGEN) Q1 2020 Earnings Call Transcript
Revenue
$76.09M
▲ 25.5% YoY Diluted EPS
$0.18
▲ 5.9% YoY Gross margin
58.0%
Rev · 8q
Audio
Transcript
Slides
8-K10-Q
Earnings call
FY19 · Q4
2020-02-20
Repligen Corp (RGEN) Q4 2019 Earnings Call
Revenue
$69.47M
▲ 33.8% YoY Diluted EPS
$0.07
▼ 41.7% YoY Gross margin
56.6%
Rev · 8q
Audio
Transcript
Slides
8-K10-K
Showing 1–30 of 30 earnings calls
Key facts
CIK
730272
CUSIP
759916109
13F (30d)
12 filings
12 filers
Visit website
Investor relations